Discovery of N-Aryl-N'-[4-(aryloxy)cyclohexyl]squaramide-Based Inhibitors of LXR/SREBP-1c Signaling Pathway Ameliorating Steatotic Liver Disease: Navigating the Role of SIRT6 Activation.
Nguyen LH, Cho YE, Kim S, Kim Y, Kwak J, Suh JS, Lee J, Son K, Kim M, Jang ES, Song N, Choi B, Kim J, Tak Y, Hwang T, Jo J, Lee EW, Kim SB, Kim S, Kwon OB, Kim S, Lee SR, Lee H, Kim TJ, Hwang S, Yun H.
Nguyen LH, et al. Among authors: kim sb, kim s, kim tj, kim m, kim j, kim y.
J Med Chem. 2024 Oct 10;67(19):17608-17628. doi: 10.1021/acs.jmedchem.4c01597. Epub 2024 Sep 11.
J Med Chem. 2024.
PMID: 39259827